These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36272042)

  • 21. Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.
    Abdelrahman KS; Hassan HA; Abdel-Aziz SA; Marzouk AA; Shams R; Osawa K; Abdel-Aziz M; Konno H
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH; Zaki MA
    Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers.
    El-Sharief AMS; Ammar YA; Belal A; El-Sharief MAMS; Mohamed YA; Mehany ABM; Elhag Ali GAM; Ragab A
    Bioorg Chem; 2019 Apr; 85():399-412. PubMed ID: 30665034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors.
    Nawareg NA; Mostafa AS; El-Messery SM; Nasr MNA
    Bioorg Chem; 2022 Oct; 127():106038. PubMed ID: 35870412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
    Alanazi MM; Mahdy HA; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Dahab MA; Eissa IH
    Bioorg Chem; 2021 Jul; 112():104949. PubMed ID: 34023640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J; Khalilzadeh MA; Zareyee D
    Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
    Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
    Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and
    Shehta W; Agili F; Farag B; Youssif S; Almehmadi SJ; Elfeky SM; El-Kalyoubi S
    Future Med Chem; 2023 Apr; 15(8):661-677. PubMed ID: 37125606
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
    Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
    Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation.
    Marzouk AA; Abdel-Aziz SA; Abdelrahman KS; Wanas AS; Gouda AM; Youssif BGM; Abdel-Aziz M
    Bioorg Chem; 2020 Sep; 102():104090. PubMed ID: 32683176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
    H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7.
    Abdelhaleem EF; Kassab AE; El-Nassan HB; Khalil OM
    Med Chem; 2022; 18(8):903-914. PubMed ID: 35264093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies.
    Abourehab MAS; Alqahtani AM; Almalki FA; Zaher DM; Abdalla AN; Gouda AM; Beshr EAM
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
    Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
    Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
    Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.